Supply Obligation. Gen-Probe shall be required to supply in any Calendar Quarter the quantity of such Panther Instruments ordered by Roka pursuant to Section 3.2 to the extent such quantity of Panther Instruments was set forth in the most recent Forecast. If the quantity of Panther Instruments ordered by Roka under Section 3.2 for any Calendar Quarter exceeds the forecasted amount, Gen-Probe shall use Commercially Reasonable Efforts to work with its Third Party contract manufacturer to supply such excess. If Gen-Probe becomes aware of any fact indicating that Gen-Probe may be unable to meet Roka’s forecasted demand for Panther Instruments, Gen-Probe shall promptly provide written notice of such fact to Roka.
Supply Obligation. Gen-Probe shall be required to supply in any month the quantity of each Product ordered by Chiron pursuant to Section 6.3.3 to the extent such quantity of such Product was set forth in the most recent forecast. If the quantity of any Blood Screening Assay, Clinical Diagnostic Assay or Rare Reagent ordered by Chiron under Section 6.3.4 below for any calendar period exceeds the forecasted amount, Gen-Probe shall use its Commercially Reasonable Efforts to supply such excess. If Gen-Probe becomes aware of any fact indicating that Gen-Probe may be unable to meet Chiron's forecasted demand as to any Product, Gen-Probe shall promptly provide written notice of such fact to Chiron. The Supervisory Board shall then meet to discuss the relevant circumstances and appropriate actions.
Supply Obligation. Using the Gresham Facilities, SCI will manufacture and provide the Products to LSI and perform the Services according to the terms and conditions in this Agreement. It is expressly understood that the quality and performance standards and requirements set forth in this Agreement are intended to represent the operating experience and capability of the Gresham Facilities’ operations as conducted by LSI immediately prior to the Closing (the “Reference Point”). In the event that SCI reasonably and with adequate specificity demonstrates, and so notifies LSI in writing within ninety (90) days after the Reference Point, that the actual operating capability and performance of the Gresham Facilities’ operations as of the Reference Point are inferior to that required for performance to any of such standards or requirements specified herein such that SCI’s performance hereunder is adversely impacted to a material extent, at SCI’s request the Parties shall in good faith modify such standards or requirements so as to reflect the actual operating capability and performance of the Gresham Facilities’ operations as of the Reference Point. It is further understood that for a limited period after the Effective Date SCI will require certain assistance under the Transition Services Agreement. If an issue arises under the Transition Services Agreement that adversely impacts SCI’s ability to perform under this Agreement, the parties will discuss in good faith resolution of the issue.
Supply Obligation. 6.5.1 LTS CORP shall accept and fulfill firm purchase orders for quantities of Products
Supply Obligation. IRC shall supply one hundred percent (100%) of Product listed for the first quarterly period of each forecast, and shall have sufficient in-process inventory to produce one hundred twenty-five percent (125%) of the quantity of Product listed for the second quarterly period of each forecast. IRC shall use its commercially reasonable best efforts to accommodate any increases in quantity of Product which Trinity shall request under new orders or purchase orders (as the case may be). IRC shall meet Trinity's delivery requirements specified in accordance with this Section 6.4. IRC's obligation to supply Product, after regulatory approval to market the Product in Thailand, shall be subject to consummation of the purchase by Trinity of the shares of IRC common stock required to be purchased pursuant to Section 1.1.2 of the Stock Purchase Agreement.
Supply Obligation. QIAGEN shall use commercially reasonable efforts to manufacture and deliver those quantities of the Product duly forecasted by ArcherDX and to fill ArcherDX's orders in excess thereof.
Supply Obligation. During the term of the Supply Agreement, TAKEDA shall manufacture, or have a Third Party Manufacturer manufacture, and supply to PENINSULA all PENINSULA's requirements of Compound for processing into Products for commercial sale in the Territory as set forth in purchase orders submitted by PENINSULA;
Supply Obligation. Upon Licensee’s written request and subject to the terms of a definitive supply agreement to be negotiated by the Parties, Licensor shall manufacture and supply to Licensee (i) API at no charge for a Phase 2 ophthalmic clinical trial aimed at studying the Licensed Product in patients affected by dry eye in quantities and timeframes to be agreed; and (ii) API at Licensee’s cost for other clinical trials to be conducted by Licensee in the Territory.
Supply Obligation. Summit will supply placebo and API Bulk Drug Substance, Bulk Drug Product or Finished Drug Product, as applicable, in accordance with the Supply Agreements to be negotiated by the Parties in accordance with Section 6.2 of the Agreement and consistent with the principles set forth in this Schedule 6.2. Sarepta will purchase such placebo and Product (in the product form elected by Sarepta) exclusively from Summit or Summit’s subcontracted Third Party manufacturer (and will not obtain or otherwise purchase from any others) (i) unless a Third Party manufacturer has been established as a Second Source or Back-Up Source for Manufacture of Product, in which case Sarepta will purchase Licensed Product (in the Product form elected by Sarepta) from Summit or such Third Party manufacturer or (ii) except as set forth in the applicable Supply Agreement.
Supply Obligation. During the term of this Agreement (but subject to all required regulatory approvals for sale of the Product in the Territory), Gland agrees to manufacture and supply the Product to Sagent in accordance with the Purchase Orders issued by Sagent and in accordance with the terms of this Agreement for marketing and sale by Sagent in the Territory. Gland shall manufacture, process, and package the Product in accordance with the Specifications.
